Keros Therapeutics, Inc. Share Price

Keros Therapeutics, Inc. Share Price

NASDAQ: KROS | Small Cap
$11.74
+$0.20 (1.73%) Last updated on 29 Oct, 2026 | 20:59 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Keros Therapeutics, Inc. Stock Performance

Open
$11.56
Prev. Close
$11.54
Circuit Range
N/A
Day Range
$11.56 - $11.72
Year Range
$9.73 - $22.47
Volume
3,111
Average Traded
$11.63

Keros Therapeutics, Inc. Share Price Today

As of 29 October 2026, Keros Therapeutics, Inc.'s share price is $11.74. The stock opened at $11.56, compared to its previous close of $11.54. During today's trading session, Keros Therapeutics, Inc.'s share price traded between $11.56 and $11.72, with an average price of $11.64. Over the past 52 weeks, the stock has recorded a high of $22.47 and a low of $9.73. In terms of performance, Keros Therapeutics, Inc.'s share price has risen by 5.67% over the last six months and is down 22.76% on a year-on-year basis.

Keros Therapeutics, Inc. Share Price Chart

Line chart of the Keros Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 11.56 to 11.88, ending at 11.74.
$11.56$11.72
L
Show Current Price
H

Keros Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$436.98M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.19
Revenue (TTM)
$244.06B
Return On Equity (TTM)
-31.70%
Profit Margin
35.65%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-294.37%

Keros Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$14.26$0.39$0.37$0.00
Net Profit-$7.28-$23.46-$23.71-$28.71
Net Profit Margin-51.05%-6015.38%-6408.11%N/A
Income ChangeN/A-222.25%-1.07%-21.09%

Keros Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.15$3.55$244.06
Net Profit-$104.68-$152.99-$187.35$87.01
Net Profit MarginN/A-101993.33%-5277.46%35.65%
Income ChangeN/A-46.15%-22.46%146.44%

About Keros Therapeutics, Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Keros Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$11.19
$11.72
+3.03%
Sep 2026
$10.96
$11.38
+1.25%
Aug 2026
$10.18
$11.24
+11.95%
Jul 2026
$10.77
$10.04
-5.86%
Jun 2026
$11.03
$10.66
-5.03%
May 2026
$11.20
$11.23
+1.08%
Apr 2026
$11.49
$11.11
+0.54%
Mar 2026
$13.95
$11.05
-22.21%
Feb 2026
$18.28
$14.21
-20.55%
Jan 2026
$19.57
$17.88
-12.07%
Dec 2025
$17.50
$20.34
+16.20%
Nov 2025
$15.07
$17.50
+15.13%

KROS Share Price FAQs